How does Glimepiride interact with DPP-4 inhibitors when used in combination therapy? Are there any synergistic benefits or risks to consider?
Lakshya KumarExplorer
How does Glimepiride interact with DPP-4 inhibitors in combination therapy?
Share
Glimepiride, a sulfonylurea, enhances insulin secretion, while DPP-4 inhibitors prolong incretin effect. Together, they can improve glycemic control but may increase hypoglycemia risk.